Free cash flow swung to -$63.5M in 2026Q3 (FCF margin -29.0%) as CapEx spiked to 37.0% of revenue, while working capital absorbed $81.1M, despite operating cash flow of $17.4M covering net income 7.6 times.
Universal Technical Institute, Inc. (UTI) cash flow statement — 26-year operating, investing & financing cash flows
| Metric | TTM | Sep'25 | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Sep'09 | Sep'08 | Sep'07 | Sep'06 | Sep'05 | Sep'04 | Sep'03 | Sep'02 | Sep'01 | Sep'00 |
|---|
| Cash from Operations | 74.51M | 97.33M | 85.89M | 49.15M | 46.03M | 55.19M | 11.03M | 21.75M | -13.48M | -9.98M | 7.38M | 8.24M | 27.06M | 26.73M | 18.51M | 58.07M | 67.48M | 49.15M | 21.09M | 39.63M | 45.41M | 67.76M | 47.66M | 36.42M | 20.47M | 0 | 21.05M |
| Operating CF Margin % | - | 11.65% | 11.72% | 8.09% | 10.99% | 16.47% | 3.67% | 6.56% | -4.25% | -3.08% | 2.13% | 2.27% | 7.15% | 7.03% | 4.48% | 12.85% | 15.48% | 13.41% | 6.14% | 11.22% | 13.09% | 21.8% | 18.68% | 18.53% | 14.18% | - | 22.86% |
| Operating CF Growth % | 460.29% | 13.31% | 74.77% | 6.77% | -16.59% | 400.23% | -49.27% | 261.34% | -35.08% | -235.13% | -10.41% | -69.54% | 1.21% | 44.43% | -68.13% | -13.94% | 37.29% | 133.01% | -46.78% | -12.73% | -32.98% | 42.18% | 30.88% | 77.89% | - | -100% | - |
| Net Income | 34.3M | 63.02M | 42M | 12.32M | 25.85M | 14.58M | 8.01M | -7.87M | -32.68M | -8.13M | -47.7M | -9.15M | 2.04M | 3.81M | 9.03M | 27.24M | 28.83M | 11.73M | 8.22M | 15.56M | 27.39M | 35.82M | 28.82M | 20.38M | 9.92M | -9.74M | -36.22M |
| Depreciation & Amortization | 62.86M | 56.78M | 51.19M | 45.82M | 32.78M | 29.63M | 36.08M | 15.9M | 15.69M | 16.89M | 17.75M | 19.16M | 20.47M | 22.16M | 23.82M | 24.84M | 19.89M | 17.57M | 17.61M | 18.75M | 14.21M | 9.78M | 8.81M | 6.38M | 4.95M | 4.53M | 3.89M |
| Stock-Based Compensation | 12.18M | 9.15M | 8.56M | 3.85M | 4.34M | 1.73M | 2.08M | 1.39M | 1.81M | 2.94M | 4.9M | 4.26M | 5.72M | 6.22M | 6.49M | 6.28M | 5.89M | 4.7M | 5.33M | 6.44M | 1.21M | 808K | 808K | 0 | 0 | 0 | 0 |
| Deferred Taxes | 83K | -1.34M | 4.44M | 4.64M | -6.01M | 1.44M | 345K | 767K | -2.81M | 254K | 27.93M | -5.39M | -4.05M | -3.79M | -8.49M | 2.51M | -3.54M | -2.17M | -249K | -957K | -2.39M | -1.7M | 3.3M | 484K | 2.04M | 0 | 0 |
| Other Non-Cash Items | 31.38M | 23.86M | 7.99M | 5.22M | 7.84M | 351K | 2.26M | 863K | 2.44M | -1.12M | 879K | 14.17M | 5.21M | 5.04M | 6.46M | 9.35M | 6.44M | 7.74M | 5.59M | 4.05M | 8.65M | 5.06M | 4.48M | 4M | 3.65M | 9.78M | 11.28M |
| Working Capital Changes | -66.28M | -54.15M | -28.28M | -22.7M | -18.76M | 7.45M | -37.73M | 10.69M | 2.07M | -20.81M | 3.62M | -14.81M | -2.33M | -6.71M | -18.81M | -12.15M | 9.97M | 9.58M | -15.4M | -4.22M | -3.65M | 18M | 1.44M | 5.17M | -94K | -4.57M | 21.05M |
| Change in Receivables | -44.48M | -43.95M | -17.93M | -5.73M | 816K | 8.48M | -13.75M | -1.48M | -2.69M | -2.98M | 8.2M | -11.44M | -2.7M | -1.26M | -10.11M | -9.89M | -9.89M | -1.94M | -11.31M | -1.63M | -5.32M | -2.56M | -2.56M | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | -22.49M | 0 | -19.78M | -21.75M | 5.08M | 2.5M | 522K | -1.04M | 123K | 726K | 3.83M | -4.05M | -14.48M | 14.34M | 3.4M | -5.57M | -394K | 2.34M | 170K | -9.18M | -108K | 0 | 0 | 0 |
| Change in Payables | 4.37M | 0 | 0 | -5.88M | 5.65M | 1.79M | 7.02M | 2.94M | 3.86M | -4.76M | 1.85M | 2.71M | -1.86M | -700K | 3.04M | 6.04M | 6.04M | 6.99M | 109K | -2.16M | 4.65M | 6.58M | 6.58M | 0 | 0 | 0 | 0 |
| Cash from Investing | -89.34M | -87.88M | -24M | -44.07M | -134.6M | -22.95M | -45.76M | -6.15M | 28.02M | -52.17M | 17.35M | -2.68M | -9.2M | -20.76M | -16.58M | -53.99M | -42.12M | -57.05M | 12.98M | -6.39M | -29.87M | -61.48M | -16.94M | -11.65M | -5.78M | 0 | 0 |
| Capital Expenditures | -97.38M | -41.98M | -24.3M | -56.69M | -79.46M | -61.59M | -9.26M | -6.45M | -20.93M | -8.77M | -8.07M | -29.48M | -12.02M | -9.35M | -11.34M | -29.1M | -37.2M | -28.52M | -17.7M | -46.58M | -46.14M | -45.84M | -16.98M | -11.98M | -11.77M | 0 | 0 |
| CapEx % of Revenue | 11.02% | 5.02% | 3.32% | 9.33% | 18.97% | 18.38% | 3.08% | 1.95% | 6.6% | 2.7% | 2.32% | 8.13% | 3.18% | 2.46% | 2.74% | 6.44% | 8.53% | 7.78% | 5.15% | 13.18% | 13.29% | 14.75% | 6.65% | 6.1% | 8.15% | - | - |
| Acquisitions | 0 | 0 | 0 | -16.38M | -26.33M | 277K | 261K | 267K | 291K | 390K | -2.02M | 464K | 568K | 54K | -90.63M | 0 | 0 | 0 | 0 | 0 | 32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -4.29M | 169K | 296K | 29M | -181K | 427K | 1.63M | 34K | 917K | 2.26M | 286K | 610K | 91K | -3.71M | 91.25M | 64K | 5K | 36K | 30.69M | 40.19M | 3K | 194K | 36K | 323K | 5.87M | 0 | 0 |
| Cash from Financing | 77.37M | -42.79M | -51.34M | 81.85M | 12.59M | 24.82M | 43.09M | -7.2M | -6.58M | -6.76M | 64.88M | -15.11M | -13.46M | -15.98M | -9.93M | 611K | -32.59M | -16.78M | -28.79M | 918K | -26.16M | 3.16M | 2.96M | -29.39M | -4.49M | 0 | 0 |
| Debt Issued (Net) | 206.18M | -38.7M | -36.52M | 88.21M | 18.77M | 30.77M | -99K | -1.32M | -1.11M | -913K | -736K | -663K | -613K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | -37K | -31.83M | -28.33M | -63.35M | 0 | 0 |
| Equity Issued (Net) | -8.73M | 659K | -23.01M | -781K | -651K | -421K | 49.15M | -629K | -223K | -595K | 68.89M | -6.62M | -1.42M | -4.9M | -1.3M | 1.27M | 4.08M | -16.06M | -29.05M | 861K | -26.95M | 3.4M | 47.32M | 0 | 42.04M | 0 | 0 |
| Dividends Paid | 0 | 0 | -1.1M | -5.07M | -5.16M | -5.25M | -5.26M | -5.25M | -5.25M | -5.25M | -2.88M | -7.31M | -9.88M | -9.82M | -7.42M | -36.33M | -36.33M | 0 | 0 | 0 | 0 | -12.56M | -12.56M | -5M | 0 | 0 | 0 |
| Share Repurchases | -8.73M | 0 | -11.5M | -781K | -651K | -421K | 0 | -629K | -223K | -595K | 0 | -6.62M | -1.42M | -5.42M | -1.85M | 0 | 0 | -16.93M | -29.54M | 0 | -30.03M | 0 | -12.95M | 0 | 0 | 0 | 0 |
| Other Financing | -120.08M | -4.75M | 9.28M | -516K | -378K | -272K | -698K | 0 | 0 | 0 | -393K | -519K | -1.55M | -1.26M | -1.21M | -658K | -336K | -723K | 251K | 57K | 798K | -199K | 28K | 3.94M | 16.82M | 0 | 0 |
| Net Change in Cash | 62.53M | -33.34M | 10.55M | 86.93M | -75.98M | 57.06M | 8.36M | 8.4M | 7.97M | -68.91M | 89.61M | -9.55M | 4.39M | -10.01M | -8.01M | 4.7M | -7.22M | -24.68M | 5.28M | 34.16M | -10.61M | 9.44M | 33.68M | -4.63M | 10.2M | 0 | 21.05M |
| Free Cash Flow | -22.87M | 55.35M | 61.6M | -7.54M | -33.43M | -6.4M | 1.77M | 15.29M | -34.41M | -18.74M | -686K | -21.24M | 15.03M | 17.38M | 7.17M | 28.97M | 30.29M | 20.63M | 3.39M | -6.95M | -722K | 21.92M | 30.69M | 24.44M | 8.7M | 0 | 21.05M |
| FCF Margin % | -2.59% | 6.62% | 8.41% | -1.24% | -7.98% | -1.91% | 0.59% | 4.61% | -10.86% | -5.78% | -0.2% | -5.86% | 3.97% | 4.57% | 1.73% | 6.41% | 6.95% | 5.63% | 0.99% | -1.97% | -0.21% | 7.05% | 12.03% | 12.44% | 6.03% | - | 22.86% |
| FCF Growth % | -130.61% | -10.14% | 917.26% | 77.45% | -422.2% | -461.64% | -88.43% | 144.44% | -83.58% | -2632.22% | 96.77% | -241.31% | -13.51% | 142.51% | -75.26% | -4.33% | 46.82% | 508.65% | 148.78% | -862.19% | -103.29% | -28.55% | 25.56% | 180.94% | - | -100% | - |
| FCF per Share | -0.41 | 1.00 | 1.21 | -0.22 | -0.99 | -0.19 | 0.06 | 0.60 | -1.37 | -0.76 | -0.03 | -0.87 | 0.60 | 0.70 | 0.29 | 1.17 | 1.24 | 0.84 | 0.13 | -0.25 | -0.03 | 0.77 | 1.11 | 0.98 | 0.43 | - | 1.57 |
| FCF Conversion (FCF/Net Income) | -0.67x | 1.54x | 2.05x | 3.99x | 1.78x | 3.78x | 1.38x | -2.76x | 0.41x | 1.23x | -0.15x | -0.90x | 13.28x | 7.02x | 2.05x | 2.13x | 2.34x | 4.19x | 2.57x | 2.55x | 1.66x | 1.89x | 1.65x | 1.79x | 2.11x | - | -0.58x |
| Interest Paid | -4.95M | 5.91M | 10.39M | -9.07M | -1.94M | 349K | 7K | 3.22M | 3.31M | 3.38M | 3.44M | 2.34M | 1.97M | 1K | 4K | 0 | 9K | 48K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | -10.36M | 11.26M | 10.68M | 658K | -859K | 6.71M | 113K | 37K | 610K | 2.7M | 1.64M | 7.01M | 3.77M | 7.47M | 15.71M | 12.62M | 23.12M | 7.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying UTI stock.
Universal Technical Institute, Inc. (UTI) generated $97.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Universal Technical Institute, Inc. (UTI) generated $55.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Universal Technical Institute, Inc. (UTI) spent $42.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
Key Metrics
Top Statement Risk
CapEx surge and working capital drag
Metrics are mathematically derived from official filings.
Earnings Quality Masked by Working Capital
In 2026Q3, UTI's operating cash flow of $17.4M was 7.6 times net income of $2.3M, but a $81.1M working capital outflow suggests earnings quality is heavily influenced by timing, per reported figures.
The OCF/NI ratio of 7.64 in 2026Q3 appears inflated by non-cash D&A of $48.0M, yet the massive working capital outflow of $81.1M indicates that cash generation is being consumed by operational needs. This divergence suggests that reported net income may not be a reliable indicator of cash-generating ability, as the company's cash conversion is volatile and dependent on working capital swings.
FCF Turns Sharply Negative
UTI's free cash flow swung from a positive $40.6M in 2025Q4 to a negative $63.5M in 2026Q3, with FCF margin deteriorating from 18.3% to -29.0%, according to the latest quarterly data.
The dramatic reversal in FCF is driven by a surge in capital expenditures to $80.9M in 2026Q3, up from $16.5M in the prior quarter, alongside a working capital outflow. This suggests that UTI is in a heavy investment phase, likely for campus expansions or new programs, which may pressure near-term cash flows despite revenue growth. Investors should monitor whether this investment translates into future revenue growth or if it strains liquidity.
Capital Intensity Spikes to 37%
CapEx as a percentage of revenue jumped to 37.0% in 2026Q3, up from 7.4% in 2025Q4, indicating a significant shift toward growth-oriented spending, as per financial statements.
The sharp increase in capital intensity suggests that UTI is investing heavily in fixed assets, likely to expand capacity or modernize facilities. While this may support long-term growth, the magnitude of the spending relative to revenue is unusually high and may strain cash flows if not matched by corresponding revenue increases. The company's ability to generate sufficient returns on this investment will be critical to sustaining its financial health.
Working Capital Swings Dominate Cash Flow
Working capital changes were a negative $81.1M in 2026Q3, reversing a positive $14.9M in 2025Q4, indicating significant cash absorption from operations, based on reported cash flow data.
The large working capital outflow in 2026Q3 suggests that UTI is experiencing a build-up in receivables or inventory, or a reduction in payables, which is consuming cash. This volatility in working capital is a key driver of the company's uneven cash flow pattern, and it may indicate inefficiencies in collections or inventory management. Analysts should monitor whether this is a seasonal effect or a sign of operational strain.
Minimal Capital Returns, Heavy Reinvestment
UTI paid no dividends and repurchased only $8.7M of stock in 2026Q3, while allocating $80.9M to capital expenditures, indicating a reinvestment-focused strategy, as per the cash flow statement.
The company's capital deployment is clearly skewed toward growth investments rather than returning cash to shareholders. With no dividends and modest buybacks, UTI appears to be prioritizing expansion, which aligns with its revenue growth trajectory. However, the lack of shareholder returns may be a concern for income-focused investors, and the effectiveness of this reinvestment strategy will be judged by future profitability.
Cumulative Cash Generation Lags Earnings
Over the last five quarters, UTI's cumulative operating cash flow of $188.4M exceeds cumulative net income of $109.7M, but the gap is narrowing due to recent working capital outflows, according to reported figures.
While operating cash flow has historically been stronger than net income, the recent quarters show a convergence, with 2026Q3's OCF/NI ratio of 7.64 masking the underlying cash consumption. The cumulative divergence suggests that earnings quality has been reasonable, but the recent working capital drag and heavy capex may indicate that future cash generation could be less robust. Investors should watch whether the company can maintain its cash conversion as it scales.
What Could Invalidate the Base Case
The reported cash flow may obscure the impact of stock-based compensation, which totaled $9.4M in 2026Q3, and the sustainability of the CapEx surge remains uncertain, per the cash flow statement.
While the cash flow statement shows strong operating cash flow relative to net income, the inclusion of SBC as a non-cash add-back may overstate cash generation. Additionally, the massive CapEx in 2026Q3 could be a one-time event or the start of a prolonged investment cycle, which would further pressure FCF. Investors should scrutinize whether the working capital outflows are temporary or indicative of structural inefficiencies, as this could materially alter the company's cash flow trajectory.